Biogen's Hot Streak of Beating Earnings Estimates
Why Biogen Idec (BIIB) is Poised to Beat Earnings Estimates by Zacks Investment Research
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Biogen Idec Inc. (BIIB), a firm in the biotechnology industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, BIIB has beaten estimates by at least 15% in both cases, suggesting it has a nice short-term history of crushing expectations.
"Profit Rockets" Stock Picks Free Trial
We issued a buy long recommendation on Biogen to all of our "Profit Rockets" subscribers back at the end of August 2013. This position is currently earning a 60% return, and we expect Biogen to continue higher. Click the link above for more information and a free trial of our "Profit Rockets" Stock Pick Service.
08/28/13 - Buy Biogen Idec - BIIB
Buy Entry: 203.54 to 210.99
Stop-Loss: 194.65
Take Profit Areas: 233.76 to 237.47, 241.27 to 245.56, 264.58 to 268.98, 309.48 to 314.76
Biogen Earnings in Focus
Two quarters ago, BIIB expected to earn $2.80 per share, while it actually produced earnings of $3.49 per share, a beat of 24.6%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of $3.22 per share, when it actually saw earnings of $3.79 per share instead, representing a 17.7% positive surprise.
Thanks in part to this history, recent estimates have been moving higher for Biogen Idec. In fact, the Earnings ESP for BIIB is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company's earnings prospects. This is the case for BIIB, as the firm currently has a Zacks Earnings ESP of 1.34%, so another beat could be around the corner.
This is particularly true when you consider that BIIB has a great Zacks Rank #1 (Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that BIIB could see another beat at its next report, especially if recent trends are any guide.
Click here for a Free Trial of Zacks Investment Research
Steve Nisons Candlestick Charting Intensive Training and Software
for Profitably Trading Stocks Forex Futures Commodities
Use the CandleScanner trading software to automatically scan for profitable trading setups on any timeframe. Stock forex and futures candlestick trading courses to throughly understand how to profit from candlestick chart patterns. Free newsletter and live trading webinars. Steve Nison is the authority on trading and profiting using candlesticks.
Track n Trade CandleStick Auto-Recognition Plug-in
Quickly identify candlestick patterns without thinking. With Track 'n Trade, you have the ability to click, and select your favorite candle patterns, and have Track 'n Trade find, identify, and even auto-trade each signal through our famed Autopilot Trading System.
Van Tharp Institute
Investing Trading Home Study Programs & Live Seminars Workshops
Dedicated to cutting edge, high quality professional educational investing trading programs for traders and investors providing a road map for financial freedom. The finest investing trading education in the financial universe. Dr Van Tharp is one of the orginal Market Wizards, and referred to as the Traders Coach.
Stock Option Forex Futures Training Seminars Webinars Workshops
Click Here For The Complete 2015 Schedule
Professional investors traders teaching successful low-risk high-reward
trade strategies. Power profit secrets for stocks, options, forex, futures
investing trading success. Or avail of Home Study Courses and or
Trading Softwares available to improve your investment returns.